Mitchell Silver, DO
Interventional Cardiology · Columbus, OHNPI 1265437628
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Inari Medical, Inc. at 53.8% of the total. Reporting peaked in 2023 at $180,141 and has fallen 99.2% since, to $1,509 in 2025. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 490 payments — averaging $1147.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$302K
- Contego Medical, Inc$100K
- E.r. Squibb & Sons, L.L.C.$44K
- Boston Scientific$39K
- Cook Incorporated$19K
- Medtronic$19K
- plus $39K from 22 others
Across 73 payments — averaging $1988.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$74K
- Contego Medical, Inc$45K
- Endologix LLC$14K
- W. L. Gore & Associates, Inc.$8K
- Medtronic$3K
- Cordis Corporation$1K
Across 7 payments — averaging $64,652 each. An ownership or investment interest held by the physician or an immediate family member.
- Contego Medical, Inc$453K
What the payments were for
- Consulting fees$310,43855%
- Speaking & faculty fees$194,44635%
- Travel & lodging$31,4846%
- Food & beverage$21,3184%
- Education$2,6510%
- Ownership interest$1,7000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 160 | $302,153 |
| Contego Medical, Inc | 47 | $100,156 |
| E.r. Squibb & Sons, L.L.C. | 26 | $43,802 |
| Boston Scientific | 58 | $38,937 |
| Cook Incorporated | 7 | $18,975 |
| Medtronic(2 entities) | 51 | $18,640 |
| Pfizer | 9 | $11,729 |
| W. L. Gore & Associates, Inc. | 44 | $10,766 |
| AstraZeneca(2 entities) | 7 | $6,368 |
| Portola Pharmaceuticals, LLC | 2 | $2,364 |
| Mercator Medsystems, Inc. | 3 | $1,878 |
| Vesper Medical | 1 | $1,500 |
| Cook Medical LLC | 18 | $1,286 |
| Biotronik Inc. | 33 | $759 |
| Terumo Medical Corporation | 3 | $758 |
| Abbott | 6 | $476 |
| Angiodynamics, Inc. | 3 | $354 |
| Argon Medical Devices, Inc. | 1 | $250 |
| Centerline Biomedical Inc. | 1 | $173 |
| Endologix LLC | 1 | $148 |
| Bard Peripheral Vascular, Inc. | 2 | $131 |
| Itamar Medical Inc | 1 | $118 |
| Cvrx, Inc. | 1 | $101 |
| Johnson & Johnson | 1 | $71 |
| Philips North America LLC | 1 | $63 |
| Avantec Vascular Corporation | 1 | $50 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$312,582
- FLOWTRIEVER CATHETER, S$154,723
- FlowTriever$67,439
- ClotTriever$67,439
- ELIQUIS$54,729
- GENERAL - THERAPIES$24,373
- Zilver Vena$13,001
- ANDEXXA$8,703
- Product in Development$7,020
- Abre$6,939
- ANGIOJET$6,273
- VenaSeal$5,400
- Cook Medical IAA$3,075
- Cook Medical Stents$3,000
- GENERAL METALLIC STENTS$3,000
- GENERAL VASCULAR INTERVENTION$2,494
- Bullfrog$1,803
- DUO Venous Stent System$1,500
- GORE TAG Thoracic Branch Endoprosthesis$680
- EXCLUDER Iliac Branch Endoprosthesis$505
How this compares
$562,037 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 268 | $278,860 |
| XareltoRivaroxaban | 102 | $88,297 |
| BrilintaTicagrelor | 11 | $11,831 |
| ClopidogrelClopidogrel Bisulfate | 447 | $4,474 |
| Atorvastatin Calcium | 286 | $2,097 |
| Cilostazol | 94 | $1,776 |
| Rosuvastatin Calcium | 128 | $1,453 |
| Nifedipine ErNifedipine | 30 | $1,430 |
| Ezetimibe | 60 | $1,287 |
| Valsartan | 33 | $916 |
| Metoprolol Succinate | 66 | $813 |
| Losartan Potassium | 82 | $696 |
| Prasugrel Hcl | 16 | $624 |
| Amlodipine Besylate | 142 | $550 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $436 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $11,729 | $278,860268 claims |
| Johnson & JohnsonXarelto | $71 | $88,297102 claims |
| AstraZenecaBrilinta | $6,368 | $11,83111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- John PhillipsColumbus$410K
- Michael JollyColumbus$281K
- Timothy SmithColumbus$149K
- Christopher HuffColumbus$119K
- Joseph CampbellColumbus$114K
- Aref AmroColumbus$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.